347 related articles for article (PubMed ID: 24801725)
1. Cardiolipin metabolism and the role it plays in heart failure and mitochondrial supercomplex formation.
Mejia EM; Cole LK; Hatch GM
Cardiovasc Hematol Disord Drug Targets; 2014; 14(2):98-106. PubMed ID: 24801725
[TBL] [Abstract][Full Text] [Related]
2. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
3. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
[TBL] [Abstract][Full Text] [Related]
4. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
5. Differential reduction in cardiac and liver monolysocardiolipin acyltransferase-1 and reduction in cardiac and liver tetralinoleoyl-cardiolipin in the α-subunit of trifunctional protein heterozygous knockout mice.
Mejia EM; Ibdah JA; Sparagna GC; Hatch GM
Biochem J; 2015 Oct; 471(1):123-9. PubMed ID: 26251360
[TBL] [Abstract][Full Text] [Related]
6. Cardiac metabolic pathways affected in the mouse model of barth syndrome.
Huang Y; Powers C; Madala SK; Greis KD; Haffey WD; Towbin JA; Purevjav E; Javadov S; Strauss AW; Khuchua Z
PLoS One; 2015; 10(6):e0128561. PubMed ID: 26030409
[TBL] [Abstract][Full Text] [Related]
7. Barth syndrome: cardiolipin, cellular pathophysiology, management, and novel therapeutic targets.
Zegallai HM; Hatch GM
Mol Cell Biochem; 2021 Mar; 476(3):1605-1629. PubMed ID: 33415565
[TBL] [Abstract][Full Text] [Related]
8. Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.
Le CH; Benage LG; Specht KS; Li Puma LC; Mulligan CM; Heuberger AL; Prenni JE; Claypool SM; Chatfield KC; Sparagna GC; Chicco AJ
J Biol Chem; 2020 Aug; 295(35):12485-12497. PubMed ID: 32665401
[TBL] [Abstract][Full Text] [Related]
9. Cardiolipin biosynthesis and remodeling enzymes are altered during development of heart failure.
Saini-Chohan HK; Holmes MG; Chicco AJ; Taylor WA; Moore RL; McCune SA; Hickson-Bick DL; Hatch GM; Sparagna GC
J Lipid Res; 2009 Aug; 50(8):1600-8. PubMed ID: 19001357
[TBL] [Abstract][Full Text] [Related]
10. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
[TBL] [Abstract][Full Text] [Related]
11. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation.
Taylor WA; Mejia EM; Mitchell RW; Choy PC; Sparagna GC; Hatch GM
PLoS One; 2012; 7(11):e48628. PubMed ID: 23152787
[TBL] [Abstract][Full Text] [Related]
12. Cardiolipin remodeling in Barth syndrome and other hereditary cardiomyopathies.
Bertero E; Kutschka I; Maack C; Dudek J
Biochim Biophys Acta Mol Basis Dis; 2020 Aug; 1866(8):165803. PubMed ID: 32348916
[TBL] [Abstract][Full Text] [Related]
13. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
[TBL] [Abstract][Full Text] [Related]
14. Cardiac mitochondrial structure and function in tafazzin-knockdown mice.
Kim J; Lee K; Fujioka H; Tandler B; Hoppel CL
Mitochondrion; 2018 Nov; 43():53-62. PubMed ID: 30389594
[TBL] [Abstract][Full Text] [Related]
15. Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
Ikon N; Ryan RO
Lipids; 2017 Feb; 52(2):99-108. PubMed ID: 28070695
[TBL] [Abstract][Full Text] [Related]
16. Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia.
Chowdhury A; Aich A; Jain G; Wozny K; Lüchtenborg C; Hartmann M; Bernhard O; Balleiniger M; Alfar EA; Zieseniss A; Toischer K; Guan K; Rizzoli SO; Brügger B; Fischer A; Katschinski DM; Rehling P; Dudek J
Cell Rep; 2018 Oct; 25(3):561-570.e6. PubMed ID: 30332638
[TBL] [Abstract][Full Text] [Related]
17. Cardiolipin remodeling in diabetic heart.
He Q; Han X
Chem Phys Lipids; 2014 Apr; 179():75-81. PubMed ID: 24189589
[TBL] [Abstract][Full Text] [Related]
18. Cardiolipin metabolism and its causal role in the etiology of the inherited cardiomyopathy Barth syndrome.
Gaspard GJ; McMaster CR
Chem Phys Lipids; 2015 Dec; 193():1-10. PubMed ID: 26415690
[TBL] [Abstract][Full Text] [Related]
19. Acylation of monolysocardiolipin in rat heart.
Ma BJ; Taylor WA; Dolinsky VW; Hatch GM
J Lipid Res; 1999 Oct; 40(10):1837-45. PubMed ID: 10508203
[TBL] [Abstract][Full Text] [Related]
20. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]